Delta-like protein 3 (DLL3) is a ligand for the Notch receptor and a promising therapeutic target molecule for small cell lung cancer (SCLC) and other neuroendocrine tumors [79,80]. The gene discussed is DLL3; the disease is neuroendocrine neoplasm.